Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c1121 |
|---|---|
| Identifier | NCT06176560 |
| Trial Title | Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Mesalazine |
Participant Information
| Sponsor | Faes Farma, S.A. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-03-24 |
|---|---|
| Primary Completion Date | 2025-08-25 |
| Completion Date | 2025-08-25 |